Italy Heart Transplant Market Analysis, Data & Statistics: (Ventricular Assist Devices, Total Artificial Hearts), Region: Lombardy, Lazio, Veneto, Emilia-Romagna, Piedmont, Tuscany & others

Italy Cardiovascular Devices market size is estimates to be $XX million in 2022. HF is one of the most significant health problems in Italy, where its prevalence was estimated to be 1.4% of the population in 2009. It is estimated that about 15% of adults aged 85 and older have HF, which is more common as people get older. This high incidence rate is especially troubling given that Italy has the second-highest percentage of seniors in the world. An estimated 2.4 percent of the national healthcare budget is devoted to HF management, placing a major financial strain on the healthcare system and society as a whole.

Italy Heart Transplant Market

The anticipated total cost of HF in 2012 was close to USD 4 billion (just over €3 billion). HF is the second-ranking brand in Italy. for hospitalization for a postpartum condition. Approximately 200,000 hospitalizations for HF occur each year, 88 percent of which are in patients over the age of 65.

13,633 adult CHF patients were identified in the HSD between 2002 and 2013; men made up 48.36 percent of this cohort, while women made up 51.65 percent. An elevated PPV (predictive positive value: 96 percent) for this diagnosis was revealed by the manual review carried out on a sample of 5% of CHF cases. Without regard to gender, the total CHF prevalence rate in 2013 was 1.25 percent. Prevalence in the elderly population ranged from 1.47 percent in the 65- to 69-year-old group to 13.36 percent in patients 90 years of age or older. Males had a somewhat higher prevalence rate than females in the older age groups for this condition. The incidence of CHF as a whole was 1.99 per 1000 person-years in 2013, and it was somewhat higher in women than in males. The incidence rates also rose with age, particularly in participants 65 years of age and beyond. Incidence rates in the elderly population varied from 2.01 in patients aged 65-69 years old to 27.15 in those aged 90 years or more. the clinical, sociodemographic, and behavioral aspects of CHF patients. Men and women 65 to 75 years old were more likely to have CHF diagnosed (37.04 percent) (32.77 and 41.03 percent, respectively). In total, 2.93 percent of people smoked, 4.86 percent of people had quit smoking, and 6.25 percent did not smoke. Men had a higher percentage of smokers than women.

According to the most recent WHO data,  in 2020 Italy has a record of 97,116 or 17.89% mortalities from Coronary Heart Disease. Italy ranks #169 in the world with a 42.43 per 100,000 people age-adjusted death rate.

Between 2008 and 2012, the combined prevalence of overweight and obesity was almost 75% in LowEd males, 70% in HighEd men, 65% in LowEd women, and 45% in HighEd women. Poor physical health is significantly influenced by inactivity. Its prevalence declined in both genders during the decade under study here, but it persisted as a problem in the second survey, where it affected about 30% of men and more than 40% of women. Men experienced a greater decline in the prevalence of current smokers over the 10 years than did women. In males, and to a greater extent in women, the prevalence of current smokers declined over ten years. High-educated people. Although there was no statistically significant difference between educational levels in the proportion of current smokers among women, it was higher in HighEd subjects than in LowEd subjects. The proportion of current smokers in the HighEd group from 2008 to 2012 was quite similar for both sexes.

Italy Cardiovascular Devices Market by States

  • Lombardy Telemedicine Market
  • Lazio Telemedicine Market
  • Veneto Telemedicine Market
  • Emilia-Romagna Telemedicine Market
  • Piedmont Telemedicine Market
  • Tuscany Telemedicine Market
  • Rest of Italy

Italy Cardiovascular Devices market has been spilt into regions namely Lombardy, Lazio, Veneto, Emilia-Romagna, Piedmont, Tuscany & others.

Italy Heart Transplant Market Segments

Datavagyanik has covered each Heart Transplant in detail in terms of market size, sales volume, growth forecast. The segment and sub segment level categorization covered in the report are:

  • Product
    • Ventricular Assist Devices
      • Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices (BIVADs)
    • Total Artificial Hearts
      • SynCardia Systems
      • BiVACOR Rotary Total Artificial Heart
      • CARMAT
      • Others

Key questions answered in the Italy Heart Transplant Market Analysis Report:

  • What is the market size for ventricular assist devices in Italy?
  • What is the artificial heart market size in Italy and how is the demand rising?
  • What is the market for each ventricular assist devices (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices (BIVADs)) in Italy?
  • What is the market size for total artificial heart (SynCardia Systems, BiVACOR Rotary Total Artificial Heart, CARMAT) in Italy?
  • Who are the top market players by market share, in each product segment?
  • Which is the fastest growing business/ product segment?
  • What should be the business strategies and Go to Market strategies?

Heart Transplant in Italy: Report Deliverables

 

Summary Statistics

    • Heart Transplant in Italy Market Attractiveness Analysis
  • Ventricular Assist Devices
    • Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices (BIVADs)
  • Total Artificial Hearts
    • SynCardia Systems
    • BiVACOR Rotary Total Artificial Heart
    • CARMAT
    • Others

Heart Transplant in Italy, Market Analysis, by Segment (state level analysis)

    • Overview
    • Historical Market size ($Million), (2017 – 2021)
    • Market size ($Million), and Forecasts (2022 – 2027)

Region wise analysis

  • Lombardy revenue & volume (ventricular assist devices (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices), total artificial heart (SynCardia Systems, BiVACOR Rotary Total Artificial Heart, CARMAT)
  • Lazio revenue & volume (ventricular assist devices (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices), total artificial heart (SynCardia Systems, BiVACOR Rotary Total Artificial Heart, CARMAT)
  • Veneto revenue & volume (ventricular assist devices (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices), total artificial heart (SynCardia Systems, BiVACOR Rotary Total Artificial Heart, CARMAT)
  • Emilia-Romagna revenue & volume (ventricular assist devices (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular assist devices), total artificial heart (SynCardia Systems, BiVACOR Rotary Total Artificial Heart, CARMAT)
  • Piedmont (segment wise analysis)
  • Tuscany (segment wise analysis)
  • Rest of Italy revenue & volume (segment wise analysis)

Pricing analysis

  • Heart replacement and treatment cost in Italy
  • Price trend and factors that impact product prices in Italy

Market forecast for 10 years

Investment strategies

 

 

“Every Organization is different and so are their requirements”- Datavagyanik

Companies We Work With

Do You Want To Boost Your Business?

drop us a line and keep in touch

Shopping Cart

Request a Free Sample

Add the power of Impeccable research,  become a DV client

Contact Info